The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.

Phillip Frost; Chairman of the Board, Chief Executive Officer; OPKO Health Inc Elias Zerhouni; President, Vice Chairman of the Board; OPKO Health Inc Good day. And welcome to the OPKO Health fourth ...

Elias Zerhouni listens to the gripes at his third town hall meeting with employees since becoming director of the National Institutes of Health nearly two years ago. The Bethesda, Md., campus lacks ...

Starting this month, a former physician took on the unenviable task of serving as the interim-director of the National Institutes of Health, assuming the reins from ...

Dr. Zerhouni is director of the National Institutes of Health. Rachel Gotbaum, the interviewer, is an independent producer based in Boston.

Operator Good day, and welcome to the OPKO Health fourth quarter 2024 financial results conference call. All participants will be in a listen-only mode. [Operator instructions] After today's ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.